Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.
Also called NCT03280745
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 165 participants
- Registry
-
NCT03280745
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03280745. Randomized; quadruple masking; primary purpose prevention. Start 2018-02-27 (actual); primary completion 2019-05-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
- Acronym
- HERACLES
- Condition
- Cardiovascular Diseases
- Condition
- Valvular Heart Disease
- Intervention (Drug)
- Hypertonic saline
- Intervention (Drug)
- 0.9% saline
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
Record details
- Record id
cardio:ct-nct03280745- Content hash
00599ef01ba10b2837e0eb229683286a502ae154ca8f867f1e283858a3a2807c